Picture of Xintela AB logo

XINT Xintela AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Xintela AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
R2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSInterim ReportInterim ReportARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-38-33.9-59.6-69.1-57.2
Depreciation
Non-Cash Items00-3.055.82
Other Non-Cash Items
Changes in Working Capital3.0291.21-5.23-5.46
Change in Accounts Receivable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-30.9-21.3-54.9-73.1-53.1
Capital Expenditures-1.62-0.383-2.430-0.104
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.9140.0540.0530.2240
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-2.53-0.329-2.380.224-0.104
Financing Cash Flow Items-5.46-13.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.4454.834.770.451.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3133.2-22.6-2.8-0.534